Sometimes the state of healthcare seems more like the movie “Snakes on a Plane” rather than the symbol of the serpent entwined on the Rod of Asclepius (the Greek god associated with healing and medicine). The movie title alone conjures pretty frightening images. The good news is that the rising numbers for healthcare investment, information technology spending, and consumer behavior related to their healthcare choices reveal a course change that’s not reptilian at all:
- According to a recent report in MedCity News, healthcare spending on telecommunications will outpace overall healthcare industry growth rates—climbing to $14.4 billion by 2017, at an annual growth rate of 10 percent.
- Venture capitalists and incubators are researching both life sciences companies and IT companies—they could create matches between life science innovators and IT to spur more digital health innovations.
- Improved networks and information technology are allowing providers to leverage their traditional medical care resources (e.g., hospitals, clinics, equipment) across a larger base of remote patients. These networks and electronic health records (EHR) will allow collaboration among clinicians, care teams, patients and provider organizations. Read the rest of this entry »
Tags: consumer behavior in healthcare, Health Care, health IT, healthcare costs, healthcare efficiencies, healthcare investment, healthcare IT
Posted in Our Views | No Comments »
Sometimes, between the hotel room, the lectures, the networking, the power lunches and the data consumption at a conference, you’re on the plane home before you have time to reflect upon why you attended in the first place. I’m excited to be heading to the 18th International Molecular Medicine Tri-Conference in San Francisco this week—and I’m setting out my reasons for going this year beforehand.
I always look forward to this conference because of its balanced range of life science topics, including those with technical, scientific, business, strategy, regulatory and reimbursement slants. Within this balanced range of topics, the Tri-Con uses a channel structure to help attendees “tune in” where they can get the biggest bang for their buck. I’m excited to learn more about the following specifics within each channel:
- Diagnostics—Rapid changes are taking place on the diagnostics stage this year. Personally, I’m interested in molecular diagnostics, personalized diagnostics, cancer markers and circulating tumor cells (CTCs). I’ll be tuning in to discussions on the adoption and integration of the next generation of sequencing, companion diagnostics and the use of/characterization of CTCs.
- Drug discovery & development–Here, sessions promise updates on translational science, including the use of biomarker technology to support drug development. Read the rest of this entry »
Tags: 18th international molecular tri-conference, biologics, cancer markers, ctcs, diagnostics, drug discovery, Health Care, informatics, life sciences, medical devices, personalized diagnostics, tri-con
Posted in Our News | No Comments »
As one of the nearly 8,500 attendees at this year’s J.P. Morgan Healthcare Conference, I’m not alone in recording my observations. However, while the crowds and the climate are still fresh in my mind, I didn’t want to miss the opportunity to share some of my key takeaways. If you were there, please feel free to add your thoughts to the comments section. If you weren’t, let me know if you have any questions about a point I’ve made or curiosity you had about the conference that I haven’t covered.
Also, whether you attended or not, you may want to check out the ruminations of TheStreet.com’s Adam Feuerstein who blogged “live” from the conference as well as In Vivo’s Blog on the subject and the prose of the IR Report’s Dominic Jones.
My observations: Read the rest of this entry »
Tags: 2011, conferences, Health Care, J.P. Morgan Healthcare Conference, Ken Walz, life sciences, mHealth, Pharmaceuticals
Posted in Our Views | No Comments »